Febuxostat vs Dotinurad: Which Gout Medication Is Right for You?

Febuxostat vs Dotinurad: Two Different Paths to Lower Uric Acid If your uric acid levels keep climbing despite lifestyle changes, your doctor has probably mentioned urate-lowering therapy. Two medications often come up in that conversation: febuxostat and dotinurad. They both lower uric acid, but they get there through distinctly different routes. Picking the right one … Read more

Gout and Bone Loss: Why Your Uric Acid Is Eating Your Skeleton

Here’s the Weird Thing About Gout and Your Bones You’ve probably heard that uric acid is the villain. It crystallizes in your joints, triggers agonizing flares, and slowly damages tissue. That part is true. But here’s what catches people off guard: for years, researchers thought high uric acid might actually protect your bones. A meta-analysis … Read more

The First Pill That May Dissolve Gout Tophi: What Pozdeutinurad Could Mean for You

The First Pill That May Dissolve Gout Tophi: What Pozdeutinurad Could Mean for You If you have gout tophi, those hard lumps of uric acid crystals under your skin, you already know the frustration. You take your allopurinol or febuxostat faithfully. Your blood tests show lower uric acid. But the lumps stay. They damage your … Read more

China’s New IL-1β Blocker for Gout: What Americans Need to Know About Fuxinqibai (Efpelibikibart)

Here’s something that flew under the radar in the American gout community: In May 2026, China approved its first-ever IL-1β inhibitor specifically for acute gout flares. It’s called Fuxinqibai (development code: Efpelibikibart), marketed as Jinbeixin, and the clinical data is genuinely impressive. As someone who’s spent years tracking gout treatments for American patients, I find … Read more